Inactive Instrument

Sector Chart CytRx Corporation Nasdaq

Equities

US2328285091

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
56.61B -
39.62B
39.25B
28.28B
26.44B